Return to content in this issue

Treatment of Severe Atopic Dermatitis With Upadacitinib in Clinical Practice: Short-Term Efficacy and Safety Results

Pereyra-Rodriguez JJ¹*, Herranz P², Figueras-Nart I³, Perez B⁴, Elosua M⁵, Munera-Campos M⁶, Melgosa-Ramos J⁷, Zaragoza V⁸, Silvestre JF⁹, Campos-Domínguez M¹⁰, Guilabert A¹¹, Miquel J¹², Alcantara-Luna S¹³, de la Cueva P¹⁴, Serra-Baldrich E¹⁵, Armario-Hita JC<sup>16

1</sup>Department of Dermatology, University Hospital Virgen del Rocío, Sevilla, Spain
²Department of Dermatology, University Hospital La Paz, Madrid, Spain
³Department of Dermatology, University Hospital de Bellvitge, Barcelona, Spain
⁴Department of Dermatology, University Hospital Ramón y Cajal, Madrid, Spain
⁵Department of Dermatology, University Hospital Puerta del Hierro, Madrid, Spain
⁶Department of Dermatology, University Hospital Germans Trias i Pujol, Badalona, Spain
⁷Department of Dermatology, University Hospital Doctor Peset, Valencia, Spain
⁸Department of Dermatology, University Hospital General de Valencia, Valencia, Spain
⁹Department of Dermatology, University Hospital of Alicante, Alicante, Spain
¹⁰Department of Dermatology, University Hospital Gregorio Marañón, Madrid, Spain
¹¹Department of Dermatology, General Hospital of Granollers, Barcelona, Spain
¹²Department of Dermatology, University Hospital Arnau de Vilanova, Valencia, Spain
¹³Department of Dermatology, Juan Ramón Jiménez Hospital, Huelva, Spain
¹⁴Department of Dermatology, Infanta Leonor Hospital, Madrid, Spain
¹⁵Department of Dermatology, Sant Pau Hospital, Barcelona, Spain
¹⁶Department of Dermatology, University Hospital Puerto Real, Puerto Real, Spain

J Investig Allergol Clin Immunol 2023; Vol 33(3) : 211-213
doi: 10.18176/jiaci.0831